Wellington Management Group’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Wellington Management Group’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-341,327	Closed	-$1.88M	–	2193
2022 Q2	$1.88M	Sell	341,327 -750,092	-69%	-$2.33M	﹤0.01%	1553
2022 Q1	$2.54M	Sell	1,091,419 -3,200,722	-75%	-$10.9M	﹤0.01%	1552
2021 Q4	$25.9M	Sell	4,292,141 -668,016	-13%	-$6.42M	﹤0.01%	1016
2021 Q3	$68.8M	Buy	4,960,157 +1,604,942	+48%	+$18.9M	0.01%	724
2021 Q2	$43.6M	Buy	3,355,215 +709,693	+27%	+$9.5M	0.01%	866
2021 Q1	$40.7M	Buy	+2,645,522	New	+$62.4M	0.01%	864

Other funds holding GRCL

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

CIS

Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wellington Management Group's GRCL Position: Q3 2022 in Review

Wellington Management Group sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q3 2022, closing a stake of 341,327 shares — an estimated $1.88M sold.

Wellington Management Group first reported a position in GRCL in Q1 2021 and held it in 6 quarters. The position peaked at $68.8M in Q3 2021. 33 funds tracked by Wall St. Rank hold GRCL as of Q3 2022.

Wellington Management Group reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Wellington Management Group sold 341,327 Gracell Biotechnologies Inc. American Depositary Shares shares in Q3 2022, an estimated $1.88M.
Wellington Management Group first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2021 and held it in 6 quarters.
Wellington Management Group's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $68.8M in Q3 2021.
33 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q3 2022.

Based on Wellington Management Group's 13F filing for Q3 2022, filed 14 Nov 2022.